Yarrow Bioscience YARW
NASDAQ YARW
$23.60 +1.08 (+4.80%)
At close: Oct 1, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) Capital Expenditures (2017 - 2020)

Updated

Yarrow Bioscience's Capital Expenditures was $117,000 in FY2024.

Analysis

Yarrow Bioscience (YARW) Capital Expenditures (2017 - 2020) Analysis & Trends

From FY2016 onward, Yarrow Bioscience has reported Capital Expenditures for 6 years.

  • Capital Expenditures shows a five-year compound annual growth rate of -35.6% (FY2019 to FY2024).
  • The FY2024 figure marks the highest annual Capital Expenditures since FY2019.
  • Per Business Quant data, Capital Expenditures in earlier years was $113,000 in FY2020 (-89.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Yarrow Bioscience 19.32 Mn -97.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 71,000.00
Mar 31, 2020 42,000.00
Dec 31, 2019 197,000.00
Sep 30, 2019 407,000.00
Jun 30, 2019 316,000.00
Mar 31, 2019 138,000.00
Dec 31, 2018 449,000.00
Dec 31, 2017 12,000.00
API Access

Yarrow Bioscience Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=YARW&period=max&api_key=YOUR_API_KEY